Agilent Technologies, Inc. (A)
Healthcare · end-of-day data as of Oct 16, 2026
The average 12-month analyst price target for A is $173.79, 0.5% above the last close of $172.97 on Oct 16, 2026; targets range from $147.14 to $194.72. Rating consensus: Buy.
Snapshot
- P/E34.0x
- P/E vs sector+20.9%
- P/E vs own+21.6%
- Target upside+0.5%
- ConsensusBuy
- Market cap$48.77B
- FCF yield+2.9%
- Insiders-$95.97K
- Earnings in38d
- News0.00
Why it moved
Agilent Technologies, Inc. (A) fell 1.5% on Oct 16, 2026.
The market (SPY) fell 1.1%; Healthcare stocks fell 0.7%. Most of the move came from the market as a whole.
0 stories on the day (30-day average 0.5).
Market = SPY. Sector = equal-weight average of the tracked companies in the same sector, net of the market.
Price and events
Last close $172.97 · +23.5% over 1y · E earnings · D dividend · S split · A analyst rating change
Technicals
- Trendbullish
- Sector▲ +16.0%
- MAs20▲ 50▲ 100▲ 200▲
- Above MAs4 of 4 above
- MA20×50—
- RSI63
- Support-9.0%
- Resistance—
- Off 52w high-1.5%
- Off ATH-1.5%
- 52w range$172.97
- Bollingerupper half
- MACD-0.28
- ATR+2.7%
- Volume1.2x
Analyst price targets
14 firms with a target in the last 12 months · last close $172.97 · as of Oct 16, 2026
Strong buy 4 · Buy 11 · Hold 7 · Sell 0 · Strong sell 0
Revenue and free cash flow
Q3 FY2026: Revenue +8.1% year over year, free cash flow 23.4% of revenue, operating margin 23.6%.
| Q3 FY2026 | Jul 31, 2026 | $1.88B | 1.28 | $439M | 55.5% | 23.6% | 19.3% |
| Q2 FY2026 | Apr 30, 2026 | $1.83B | 1.20 | $370M | 55.0% | 21.7% | 18.5% |
| Q1 FY2026 | Jan 31, 2026 | $1.8B | 1.07 | $175M | 52.6% | 19.6% | 17.0% |
| Q4 FY2025 | Oct 31, 2025 | $1.86B | 1.53 | $452M | 51.8% | 23.8% | 23.3% |
| Q3 FY2025 | Jul 31, 2025 | $1.74B | 1.18 | $259M | 52.6% | 20.7% | 19.3% |
| Q2 FY2025 | Apr 30, 2025 | $1.67B | 0.75 | $107M | 51.9% | 18.0% | 12.9% |
| Q1 FY2025 | Jan 31, 2025 | $1.68B | 1.11 | $334M | 53.5% | 22.4% | 18.9% |
| Q4 FY2024 | Oct 31, 2024 | $1.7B | 1.22 | $388M | 53.9% | 24.0% | 20.6% |
Peers
| 20D | ||||||||
|---|---|---|---|---|---|---|---|---|
| 1 | | $172.97 | -1.5% | -1.5% | +0.5% | 34.0 | $48.77B | |
| 2 |  | $560.36 | +2.4% | -26.9% | +34.9% | 39.7 | $44.15B | |
| 3 |  | $266.90 | -1.5% | -3.0% | +3.6% | 33.1 | $43.93B | |
| 4 |  | $436.95 | -1.6% | -1.6% | +4.4% | 109.0 | $42.9B | |
| 5 |  | $262.54 | -2.0% | -10.6% | -16.6% | 49.0 | $39.64B | |
| 6 |  | $1,622.29 | -1.0% | -1.0% | -7.3% | 36.5 | $32.51B | |
| 7 |  | $235.00 | -1.7% | -4.7% | -0.5% | 24.9 | $25.94B | |
| 8 |  | $317.95 | -2.2% | -6.1% | +5.8% | 26.3 | $25.79B |
Data as of Oct 16, 2026 close.
Latest news
Sentiment classified by AI from the headline (green positive, red negative). Links open the publisher.